Nephro Care
86.05
+3.00(+3.61%)
Market Cap₹141.87 Cr
PE Ratio37.58
Company Performance:
1D+3.61%
1M+30.87%
6M-37.78%
1Y-41.08%
5Y-52.07%
View Company Insightsright
Latest news about Nephro Care
Nomura Initiates Buy Rating on Nephrocare India with Target Price of Rs 605 Apr 01, 2026
Nomura has initiated coverage on Nephrocare India with a Buy rating and Rs 605 target price. The brokerage cites the company's sticky dialysis services with recurring revenue, strong positioning of NephroPlus in concentrated markets, and expects 18.3% EBITDA CAGR driven by mid-to-high-teen revenue growth and stable margins.
no imag found